Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2013

View Archived Issues

Inflection Biosciences and CNIO present novel dual PIM/PI3K and triple PIM/PI3K/mTOR inhibitors

Oxygen Biotherapeutics closes acquisition of Phyxius Pharma's levosimendan

UCI-50027 as a promising neuroactive steroid showing anticonvulsant and anxiolytic activity in vivo

Roche reports on discovery of a novel, direct-acting, RNA polymerase enzyme inhibitor to target HCV

Xofigo obtains marketing authorization in the E.U.

Ajinomoto patents novel integrin alpha4beta7 receptor antagonists

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Toyama Chemical scientists prepare and test deuterated antiviral agents

Yale University reports discovery of cytotoxic-drug-delivering molecules for HIV

Trk-A inhibitors reported in Ono Pharmaceutical patent

Global Genomics and Metabolon partner to discover cardiovascular disease biomarkers and drug targets

Cepheid presents early data for Xpert HPV test

FDA grants orphan drug designation to Epidiolex for Dravet syndrome

Baxter and Cell Therapeutics enter licensing agreement for pacritinib

ChanRx presents promising data from the COR-ART phase II trial

French ATU granted for Vimizim in Morquio A syndrome

Eisai forms partnership to make Halaven available in the Middle East

A novel KIT gene mutation identified in papillary thyroid carcinoma

Sanofi discontinues development of fedratinib over safety concerns

Akorn acquires U.S. rights to three ophthalmic products from Merck & Co.

BARDA exercises option for continued development of AverTox against nerve agents

FDA approves Valeant's Luzu for three fungal indications

Bayer, Inception Sciences and Versant Ventures establish ophthalmology collaboration

Tolerability and immunogenicity of the live attenuated tetravalent dengue vaccine candidate TV-003

Phase Ib trial for ATU-027 planned in head and neck squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...